Smart catheter for cell-based heart attack therapy

Description

Position II - ECSEL Joint Undertaking:

As part of the EU Position project, 45 European companies and research institutions are working under the coordination of Philips to establish a distributed pilot line for intelligent catheters and implants. The partners want to realize five demonstrators that point out the innovation potential in existing markets and lay the foundation for the development of new markets.

A research team from Fraunhofer EMFT is developing a cell therapy catheter as part of the project - together with its partners alphaSIP, Ciber, Cicautxo, Philips, Johnson Matthey, Universidad Zaragoza, Universidad Complutense de Madrid, Fundación Centro de Cirugía de Mínima Invasión Jesús Usón. The developed demonstrator is going to be used for the treatment of the secondary damages of a heart attack; however, the developed technology can be transferred on different disease pictures. The Fraunhofer EMFT micropump is intended to deliver the cell suspension precisely to the affected areas of the heart muscle during surgery.

Partners

  • Philips Electronics Netherlands B.V.
  • Philips Medical Systems B.V.
  • Delft University of Technology
  • Salvia BioElectronics B.V.
  • Eindhoven University of Technology
  • Reden B.V.
  • Catena Holding BV
  • CEA LETI
  • Vermon
  • Philips Research Paris
  • Murata Integrated Passive Solutions
  • Okmetic Oy
  • Teknologian Tutkimuskeskus VTT
  • Afore Oy
  • Aalto-Korkeakoulusaatio
  • Fraunhofer IZM
  • Fraunhofer Research Institution for Microsystems and Solid State Technologies
  • Fraunhofer Institute for Photonic Microsystems
  • OSYPKA AG
  • Finetech GmbH & Co. KG
  • AMIC Angewandte Micro-Messtechnik GmbH
  • Institut für Mikroelektronik Stuttgart
  • Multi Channel Systems MCS GmbH
  • Johnson Matthey Piezo Products GmbH
  • Catena Germany GmbH
  • 3D-Micromac
  • Cortec
  • Dyconex AG